Skip to content
Catalyst

PapersPMID:24366103

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

JAMA neurology2014The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceno difference foundBody mass index
  2. Finding, moderate evidenceno difference foundUrine pH
Study, every finding
RCT
Dose studied, every finding
inosine 500 mg capsules, started at 1 capsule twice daily and titrated up to 2 capsules three times daily (maximum 3 g/day) to serum urate 6.1-7.0 or 7.1-8.0 mg/dL; mean doses 1.18 and 1.51 g/day; up to 24 months

No finding here moved its endpoint.

  • “For example, serial vital signs, serum assays and ECGs showed no effect of inosine on blood pressure (eTables 5 and 6), body mass index (BMI; eTable 7), serum glucose and cholesterol (eTables 8), or electrocardiographic parameters (eTable 9).”
    Population
    Adults with early Parkinson disease not yet requiring symptomatic treatment, serum urate below about 6 mg/dL, without gout, urolithiasis, or cardiovascular or renal disease, at US Parkinson Study Group sites; both inosine arms (titrated to mild or moderate serum urate elevation) against placebo; hydration encouraged in all arms
  • “Need for alkalinization was rare because urine pH was unaffected by inosine (eTables 2 and 3).”
    Population
    Adults with early Parkinson disease not yet requiring symptomatic treatment, serum urate below about 6 mg/dL, without gout, urolithiasis, or cardiovascular or renal disease, at US Parkinson Study Group sites; both inosine arms against placebo; urine pH self-monitored at least daily for the first 12 weeks, with potassium citrate alkalinisation in any arm for persistently acidic urine

Study record

Design
randomised controlled trial
Species
human
Population
adults with early Parkinson disease not yet requiring symptomatic treatment, serum urate below the population median (~6 mg/dL), Parkinson Study Group sites, USA
Participants
75
Comparator
placebo
Duration
731 days
Endpoints measured
41